JP2007515429A5 - - Google Patents

Download PDF

Info

Publication number
JP2007515429A5
JP2007515429A5 JP2006545607A JP2006545607A JP2007515429A5 JP 2007515429 A5 JP2007515429 A5 JP 2007515429A5 JP 2006545607 A JP2006545607 A JP 2006545607A JP 2006545607 A JP2006545607 A JP 2006545607A JP 2007515429 A5 JP2007515429 A5 JP 2007515429A5
Authority
JP
Japan
Prior art keywords
composition
alkyl
aryl
cycloalkenyl
aminocarbonyl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2006545607A
Other languages
English (en)
Japanese (ja)
Other versions
JP2007515429A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2004/043207 external-priority patent/WO2005060711A2/en
Publication of JP2007515429A publication Critical patent/JP2007515429A/ja
Publication of JP2007515429A5 publication Critical patent/JP2007515429A5/ja
Pending legal-status Critical Current

Links

JP2006545607A 2003-12-19 2004-12-20 障害を治療する方法 Pending JP2007515429A (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US53094503P 2003-12-19 2003-12-19
PCT/US2004/043207 WO2005060711A2 (en) 2003-12-19 2004-12-20 Methods of treating a disorder

Publications (2)

Publication Number Publication Date
JP2007515429A JP2007515429A (ja) 2007-06-14
JP2007515429A5 true JP2007515429A5 (https=) 2008-02-07

Family

ID=34710193

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2006545607A Pending JP2007515429A (ja) 2003-12-19 2004-12-20 障害を治療する方法

Country Status (6)

Country Link
US (1) US20050250794A1 (https=)
EP (1) EP1694323A4 (https=)
JP (1) JP2007515429A (https=)
CA (1) CA2550091A1 (https=)
MX (1) MXPA06007054A (https=)
WO (1) WO2005060711A2 (https=)

Families Citing this family (36)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20060074124A1 (en) * 2003-09-12 2006-04-06 Andrew Napper Methods of treating a disorder
PL1701940T3 (pl) * 2003-12-23 2008-11-28 H Lundbeck As Pochodne 2-(1H-indolilosulfanylo)benzyloaminy jako SSRI
JP4914346B2 (ja) * 2004-05-27 2012-04-11 ユセベ ファルマ ソシエテ アノニム ベンズオキサゾロン誘導体、その調製方法及びその使用
DK1753512T3 (da) 2004-05-28 2008-11-17 4Sc Ag Tetrahydropyridothiophener
CA2568718A1 (en) 2004-06-04 2005-12-15 Altana Pharma Ag Tetrahydropyridothiophenes for use in the treatment of cancer
CA2569623A1 (en) 2004-06-11 2005-12-22 Altana Pharma Ag Novel compounds and use of tetrahydropyridothiophenes
AR052308A1 (es) * 2004-07-16 2007-03-14 Lundbeck & Co As H Derivados de 2-(1h-indolilsulfanil)-arilamina y una composicion farmaceutica que contiene al compuesto
WO2006026619A2 (en) * 2004-08-30 2006-03-09 Government Of The United States Of America As Represented By The Secretary Department Of Health And Human Services Inhibition of viruses using rnase h inhibitors
AU2006212224A1 (en) 2005-02-09 2006-08-17 4Sc Ag Tetrahydropyridothiophenes for the treatment of proliferative diseases such as cancer
AU2006212179A1 (en) 2005-02-11 2006-08-17 4Sc Ag Tetrahydropyridothiophenes as antripoliferative agents for the treatment of cancer
EP1893618A2 (en) 2005-05-25 2008-03-05 Nycomed GmbH Tetrahydropyridothiophenes for use in the treatment of cancer
CA2609003A1 (en) 2005-05-25 2006-11-30 Nycomed Gmbh Tetrahydropyridothiophenes for use in the treatment of cancer
AR054393A1 (es) * 2005-06-17 2007-06-20 Lundbeck & Co As H Derivados de benzo(b)furano y benzo(b)tiofeno, composiciones farmaceuticas que los contienen y su uso en la fabricacion de un medicamento para el tratamiento de enfermedades mediadas por la inhibicion de la reabsorcion de neurotransmisores de amina biogenicos.
US7629473B2 (en) * 2005-06-17 2009-12-08 H. Lundbeck A/S 2-(1H-indolylsulfanyl)-aryl amine derivatives
US7649098B2 (en) * 2006-02-24 2010-01-19 Lexicon Pharmaceuticals, Inc. Imidazole-based compounds, compositions comprising them and methods of their use
TW200813018A (en) 2006-06-09 2008-03-16 Astrazeneca Ab Novel compounds
US20080021063A1 (en) * 2006-07-18 2008-01-24 Kazantsev Aleksey G Compositions and methods for modulating sirtuin activity
US8227603B2 (en) 2006-08-01 2012-07-24 Cytokinetics, Inc. Modulating skeletal muscle
US8299248B2 (en) 2006-08-02 2012-10-30 Cytokinetics, Incorporated Certain 1H-imidazo[4,5-b]pyrazin-2(3H)-ones and 1H-imidazo[4,5-b]pyrazin-2-ols and methods for their use
PL2069352T3 (pl) 2006-08-02 2014-03-31 Cytokinetics Inc Określone cząstki chemiczne, kompozycje i sposoby
WO2008060400A2 (en) * 2006-11-15 2008-05-22 Sirtris Pharmaceuticals, Inc. Sirtuin polymorphisms and methods of use thereof
EP2139478A4 (en) 2007-03-30 2010-05-05 Cytokinetics Inc CHEMICAL ENTITIES, COMPOSITIONS AND METHODS
US20100222326A1 (en) * 2007-04-27 2010-09-02 Ucb Pharma, S.A. New Heterocyclic Derivatives Useful For The Treatment of CNS Disorders
TW200920355A (en) * 2007-09-06 2009-05-16 Lexicon Pharmaceuticals Inc Compositions and methods for treating immunological and inflammatory diseases and disorders
US8119661B2 (en) 2007-09-11 2012-02-21 Astrazeneca Ab Piperidine derivatives and their use as muscarinic receptor modulators
ME01294B (me) 2007-11-27 2013-06-20 Ardea Biosciences Inc Nova jedinjenja i kompozicije i metode upotrebe
US7998976B2 (en) * 2008-02-04 2011-08-16 Cytokinetics, Inc. Certain chemical entities, compositions and methods
EP2244711A4 (en) * 2008-02-04 2011-08-24 Cytokinetics Inc CERTAIN CHEMICAL ENTITIES, COMPOSITIONS AND METHODS
US8242154B2 (en) 2008-09-04 2012-08-14 Ardea Biosciences, Inc. Compounds, compositions and methods of using same for modulating uric acid levels
WO2010077642A1 (en) * 2008-12-08 2010-07-08 Northwestern University Method of modulating hsf-1
JP2012076998A (ja) * 2009-01-29 2012-04-19 Sapporo Medical Univ メラノーマの転移抑制剤
WO2010098866A1 (en) * 2009-02-27 2010-09-02 Supergen, Inc. Cyclopentathiophene/cyclohexathiophene dna methyltransferase inhibitors
AU2010270797B2 (en) 2009-07-08 2015-03-19 Dermira (Canada), Inc. TOFA analogs useful in treating dermatological disorders or conditions
CN102985553B (zh) * 2010-04-15 2015-11-25 西特里斯药业公司 沉默调节蛋白活化剂和活化测定
WO2012119605A1 (en) * 2011-03-10 2012-09-13 Akar Yahya Ahmed Abdellhafeez Salem New disperse dye with potent anticancer activity
BR112014000742A2 (pt) 2011-07-13 2016-08-23 Andrew A Wolff terapia de combinação de als

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6414013B1 (en) * 2000-06-19 2002-07-02 Pharmacia & Upjohn S.P.A. Thiophene compounds, process for preparing the same, and pharmaceutical compositions containing the same background of the invention
IL138825A (en) * 2000-10-03 2006-06-11 Neurim Pharma 1991 Pharmaceutical preparations containing tryptamine derivatives and similar compounds, and such new compounds
EP1324759A4 (en) * 2000-10-12 2004-05-12 Smithkline Beecham Corp NF - G (K) B INHIBITORS
US20040005574A1 (en) * 2002-07-08 2004-01-08 Leonard Guarente SIR2 activity
BR0210929A (pt) * 2001-06-07 2004-06-08 Hoffmann La Roche Derivados de indol com afinidade para o receptor 5-ht6
WO2002102981A2 (en) * 2001-06-15 2002-12-27 The Trustees Of Columbia University In The City Of New York SIR2α-BASED THERAPEUTIC AND PROPHYLACTIC METHODS
HRPK20040271B3 (en) * 2001-09-27 2006-02-28 F. Hoffmann - La Roche Ag Indole derivatives as cox ii inhibitors
EP1677794B1 (en) * 2003-09-12 2014-12-03 Elixir Pharmaceuticals, Inc. Methods of treating disorder
US20050085531A1 (en) * 2003-10-03 2005-04-21 Hodge Carl N. Thiophene-based compounds exhibiting ATP-utilizing enzyme inhibitory activity, and compositions, and uses thereof
CA2553670A1 (en) * 2004-01-29 2005-08-11 Elixir Pharmaceuticals, Inc. Anti-viral therapeutics

Similar Documents

Publication Publication Date Title
JP2007515429A5 (https=)
JP2007529422A5 (https=)
WO2007120648A3 (en) Mono and di-substituted oxycodone compounds and compositions
JP2013513613A5 (https=)
MY147310A (en) A solid pharmaceutical composition containing 2-ethoxy-1-{ [2'-(5-oxo-4,5-dihydro-1,2,4-oxadiazol-3-yl) biphenyl-4-yl]methyl}-1h-benzimidazole-7-carboxylic acid or a salt thereof, a fat and oil-like substace having low melting point and a low viscosity binder
JP2003528918A5 (https=)
JP2009541489A5 (https=)
JP2008513370A5 (https=)
JP2009533410A5 (https=)
GEP20125425B (en) Biaryl ether urea compounds
TW200736232A (en) Pyrimidine derivatives
NZ597381A (en) Thiazolidinedione analogues for the treatment of diabetes and inflammatory diseases
JP2012041365A5 (https=)
AR065276A1 (es) Herbicidas de n-oxidos de piridina sustituidos
WO2007096151A3 (en) Inhibitors of p38-kinase for treatment of pulmonary hypertension
NZ593030A (en) Pyridyloxyindoles inhibitors of vegf-r2 and use thereof for treatment of disease
JP2011520906A5 (https=)
EA200971041A1 (ru) Новые пептидные ингибиторы репликации вируса гепатита с
EA200971026A1 (ru) Новые макроциклические ингибиторы репликации вируса гепатита с
EP1826197A4 (en) AMINOCARBOXYLIC ACID DERIVATIVE AND THERAPEUTIC APPLICATIONS OF SAID DERIVATIVE
JP2011006480A5 (https=)
WO2005044192A3 (en) Triazole compounds and uses related thereto
JP2017526677A5 (https=)
JP2013523893A5 (https=)
JP2018530582A5 (https=)